BPA Call 75F40126A00018-75F40126F19003
Award Date 9/24/26
Potential Completion Date 9/23/27
Potential Value $812K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
Not listed Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Great Falls, VA 22066, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration issued a BPA call to Equinoxys Inc. on September 21, 2018, for Financial Management Systems Support Services, with a ceiling value of $23,061,584.52 under the General Services Administration's Information Technology Schedule 70 (IT-70). Performance takes place in Silver Spring, Maryland. The call has a firm fixed price structure and ultimate completion date of September 23, 2024. Equinoxys is a minority-owned, self-certified small disadvantaged business...
- The Food and Drug Administration issued a BPA call to Equinoxys Inc. for $1,189,948.79 on April 12, 2023, to provide support for implementation of user fees system multi-factor authentication (MFA). Work is performed in Calverton, Maryland. The call runs through April 12, 2024. Equinoxys is a minority-owned small disadvantaged business specializing in IT services and management consulting. The call is issued under the Multiple Award Schedule (MAS) contract vehicle. Pricing is labor-hour based....
- Equinoxys Inc., doing business as Equinoxys Inc., was awarded a $836,982.21 firm fixed price blanket purchase agreement call against its Information Technology Schedule 70 contract by the Department of Health and Human Services' Food and Drug Administration. The contract calls for Equinoxys to provide implementation support for the FDA's OFM Financial Systems Business financial management system's e-invoicing functionality. Performance will take place in Calverton, Maryland over an...
- Equinoxys Inc., doing business as Equinoxys Inc., has been awarded a $93,802.72 firm-fixed-price blanket purchase agreement (BPA) call contract from the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to provide KNIME and MongoDB licenses and associated support services. Performance will take place in Rockville, Maryland under the terms of the contractor's Multiple Award Schedule contract vehicle. The one-year BPA call, which runs from September 2023 through...
- This firm-fixed-price BPA call was awarded to Equinoxys Inc., a minority-owned, self-certified small disadvantaged business, by the Food and Drug Administration (FDA) for $997,315.07. The contract is for data analytics implementation support services, including operations and maintenance, cloud migration, process automation, e-invoicing integration, and infrastructure upgrades for the agency's Unified Financial Management System (UFMS) and User Fee systems. Equinoxys has previously supported the...
- This is a $1,671,906.19 BPA Call contract awarded by the Food and Drug Administration (FDA) to Equinoxys Inc., a Minority Owned Business, Self Certified Small Disadvantaged Business, and Subcontinent Asian (Asian-Indian) American Owned company. The contract is to support the FDA's Unified Financial Management System (UFMS) and User Fee systems through IT modernization, data analytics, and professional services. Key efforts include transitioning legacy systems, unearned funds tracking, refund...
- This is a firm fixed price BPA Call order awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Equinoxys Inc., a Minority Owned, Self Certified Small Disadvantaged Business. The order, with a potential value of $53,103.92, provides support for the implementation of enhancements to the CTPCMP (Clinical Trials Program Compliance Monitoring Program) portal and reporting capabilities. Equinoxys Inc. is an IT services and management consulting firm with...
- The Food and Drug Administration issued a BPA call to Tyrula, LLC, an 8(a) Program Participant and certified Economically Disadvantaged Women-Owned Small Business, with a ceiling value of $1,150,558.84 on July 30, 2026. This is Task Order 7 under the FDA's Administrative Operations Information System (AOIS) BPA, a $49.9 million blanket purchase agreement for administrative operations support across the agency. Performance is located in Silver Spring, Maryland, with an ultimate completion date of...
- The Food and Drug Administration issued a BPA call to Booz Allen Hamilton Inc. for NextGen RBIS ORA firm development, modernization, and enhancement, with a ceiling value of $584,828.03, awarded on September 17, 2024. The call is issued under the Multiple Award Schedule (MAS) BPA. Place of performance is North Bethesda, Maryland. The ultimate completion date is September 17, 2025. Work involves development, modernization, and enhancement services for the NextGen RBIS ORA system using labor hours...
- The Food and Drug Administration issued a BPA call to Booz Allen Hamilton Inc. on April 2, 2025, under the Multiple Award Schedule (MAS) for NextGen Regulatory Business Information System (RBIS) Operations and Maintenance and Development, Modernization and Enhancement, with a ceiling value of $10,070,841.92. This is Modification 5, a non-cost extension extending the ultimate completion date to July 31, 2026. Work is performed in Silver Spring, Maryland. The call requires labor-hour pricing to...
- Multiple Award Schedule (MAS)Master GSA Schedule
- 47QTCA25D007F-75F40126A00018Blanket Purchase Agreement
- 75F40126A00018-75F40126F19003BPA Call
The Food and Drug Administration issued a BPA call to Equinoxys Inc. on September 24, 2026, for Budget Execution Transformation Initiative (BETI) Assessment under the FDA Financial Systems Support Services (FSSS) BPA, with a ceiling value of $811,985.95. The call is firm fixed price and runs through September 23, 2027. Work is performed in Great Falls, Virginia. Equinoxys is a minority-owned, self-certified small disadvantaged business. The engagement supports financial systems modernization and assessment activities aligned with the FDA's broader financial management infrastructure priorities.
Generated 9/19/26, 9:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $812.0k | 9/18/26 |